{"name":"Bionorica SE","slug":"bionorica-se","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Sinupret extract coated tablets","genericName":"Sinupret extract coated tablets","slug":"sinupret-extract-coated-tablets","indication":"Acute sinusitis","status":"phase_3"},{"name":"Placebo coated tablets","genericName":"Placebo coated tablets","slug":"placebo-coated-tablets","indication":"Clinical trial control comparator (non-therapeutic use)","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"neuroscience","drugs":[{"name":"BX-1","genericName":"BX-1","slug":"bx-1","indication":"Respiratory tract infections or related respiratory conditions (specific indication not publicly detailed)","status":"phase_3"},{"name":"Canephron® N","genericName":"Canephron® N","slug":"canephron-n","indication":"Acute and chronic urinary tract infections","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"VAC BNO 1095 film coated tablets","genericName":"VAC BNO 1095 film coated tablets","slug":"vac-bno-1095-film-coated-tablets","indication":"Immune support and inflammatory conditions (specific indication under Phase 3 evaluation not publicly detailed)","status":"phase_3"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"BNO 1016","genericName":"BNO 1016","slug":"bno-1016","indication":"Acute bronchitis with productive cough","status":"phase_3"}]}],"pipeline":[{"name":"Sinupret extract coated tablets","genericName":"Sinupret extract coated tablets","slug":"sinupret-extract-coated-tablets","phase":"phase_3","mechanism":"Sinupret extract is a herbal combination that reduces inflammation and promotes drainage in the sinuses and respiratory tract.","indications":["Acute sinusitis","Chronic sinusitis","Rhinosinusitis"],"catalyst":""},{"name":"VAC BNO 1095 film coated tablets","genericName":"VAC BNO 1095 film coated tablets","slug":"vac-bno-1095-film-coated-tablets","phase":"phase_3","mechanism":"VAC BNO 1095 is a herbal film-coated tablet formulation that modulates immune and inflammatory responses through its botanical active constituents.","indications":["Immune support and inflammatory conditions (specific indication under Phase 3 evaluation not publicly detailed)"],"catalyst":""},{"name":"BNO 1016","genericName":"BNO 1016","slug":"bno-1016","phase":"phase_3","mechanism":"BNO 1016 is a herbal combination product that modulates immune and inflammatory responses to support respiratory health.","indications":["Acute bronchitis with productive cough","Chronic obstructive pulmonary disease (COPD) exacerbations"],"catalyst":""},{"name":"BX-1","genericName":"BX-1","slug":"bx-1","phase":"phase_3","mechanism":"BX-1 is a herbal extract combination that modulates immune and inflammatory pathways to support respiratory and immune function.","indications":["Respiratory tract infections or related respiratory conditions (specific indication not publicly detailed)"],"catalyst":""},{"name":"Canephron® N","genericName":"Canephron® N","slug":"canephron-n","phase":"phase_3","mechanism":"Canephron N is a herbal combination that reduces inflammation and supports kidney and urinary tract function through diuretic and antimicrobial properties.","indications":["Acute and chronic urinary tract infections","Prevention of recurrent urinary tract infections","Supportive treatment of kidney and bladder conditions"],"catalyst":""},{"name":"Placebo coated tablets","genericName":"Placebo coated tablets","slug":"placebo-coated-tablets","phase":"phase_3","mechanism":"Placebo coated tablets contain no active pharmaceutical ingredient and work through the placebo effect, where the expectation of treatment produces therapeutic benefit independent of pharmacological action.","indications":["Clinical trial control comparator (non-therapeutic use)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQbEVySDY1emN1T08teWRVN2lxX2ZlaG5pclI5blRwbmpjSmRURWhJQXdXaFhJdmlxY1lmXzBuYXpxSFZaZm1HTUFKcThqOWw4QWk2LTUwS0ozMC15bDYyejNFeUF6cDJOOW5hQTUtTm9sdTVkejVkYl8zTFU3NndkOExWTHltUQ?oc=5","date":"2024-10-22","type":"pipeline","source":"Grand View Research","summary":"Europe Herbal Medicine Market Size & Outlook, 2024-2030 - Grand View Research","headline":"Europe Herbal Medicine Market Size & Outlook, 2024-2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPN2RKQVBiczdBRGs4Zi1mWDNWalAtSU41RkhkY0tfaVMyMnJBc2NlVERsN1hhemE5VWdpeEtpRmVOSldJSGFVSlc0ZTRDdm0taFJLZ2hXRkdoRVI1N1ZoMml4U2tRSW5WbTNod3l6NVFFU1pyVUFhSGxDVzZyVV9ad19kcGtPWTlMNS1qdDNGZ0VMbVpuQldPeW5mV3VlZnNDUXFJME1SX2pKTjRQZ1JCbzAyQllIX29Ec1o4?oc=5","date":"2019-05-02","type":"deal","source":"PR Newswire","summary":"Canopy Growth Acquires Germany's C3 Cannabinoid Compound Company - PR Newswire","headline":"Canopy Growth Acquires Germany's C3 Cannabinoid Compound Company","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_3":6},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}